Clinical Trial Update: Study of SCH 527123 in Subjects With Severe Asthma (Study P05109AM1) [Phase 2]

View source ↗

Summary

A Phase 2 trial of SCH 527123 in subjects with severe asthma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• SCH 527123

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Asthma | Phase 2 | Status: WITHDRAWN